Connect Sign In
ARUP is leveraging artificial intelligence (AI) to streamline testing processes so that more accurate results can be delivered faster.
Tracy George, MD, has been named one of the Top 10 Influential Women by Utah Business magazine, recognizing her leadership in advancing diagnostic innovation, science, and patient care.
Tracy George, MD, is a champion for patients with rare and undiagnosed conditions and will speak about ARUP’s innovative efforts that support the rare disease community.
ARUP’s Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating next generation diagnostics from concept to commercialization.
ARUP is the first U.S. lab to validate Rarity Bioscience’s ultrasensitive superRCA™ assay, which advances high-precision mutation detection and supports innovation in clinical and trial settings.
RIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders characterized by abnormal lymph node enlargement and systemic inflammatory symptoms that can be…
Tracy George, MD, ARUP chief scientific officer and Innovation Business Unit president, will help advance life sciences innovation and strengthen Utah’s healthcare ecosystem with BioUtah.
Deploying artificial intelligence (AI) solutions in the lab brings several challenges. In this white paper, ARUP experts offer actionable advice for determining whether AI is right for your lab.
ARUP’s central pathology review service has provided key support for the Cogent SUMMIT trial through robust laboratory testing, mastocytosis pathology expertise, and rigorous quality standards.
ARUP Laboratories now offers a test for pTau 217 to aid in the detection of Alzheimer’s disease pathology. This test is minimally invasive and more accessible than other types of diagnostic testing.
